ALEC Insider Transactions
329 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
ALEC insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Wong-Sarad Grace | Principal Accounting Officer | 2026-06-03 | Sale | 3,475.0 | $1.88 |
| Rosenthal Arnon | Chief Executive Officer | 2026-06-02 | Sale | 87,216.0 | $1.97 |
| Wong-Sarad Grace | Principal Accounting Officer | 2026-06-02 | Sale | 5,709.0 | $1.97 |
| Berkley Neil Lindsay | CFO & Chief Business Officer | 2026-06-02 | Sale | 19,360.0 | $1.97 |
| Wong-Sarad Grace | Principal Accounting Officer | 2026-04-16 | Sale | 1,820.0 | $2.65 |
| Wong-Sarad Grace | Principal Accounting Officer | 2026-03-10 | Sale | 1,000.0 | $2.65 |
| Wong-Sarad Grace | Principal Accounting Officer | 2026-03-03 | Sale | 3,367.0 | $2.08 |
| Berkley Neil Lindsay | CFO & Chief Business Officer | 2026-03-02 | Sale | 29,649.0 | $2.12 |
| Wong-Sarad Grace | Principal Accounting Officer | 2026-03-02 | Sale | 8,071.0 | $2.12 |
| Rosenthal Arnon | Chief Executive Officer | 2026-03-02 | Sale | 81,864.0 | $2.12 |
| Wong-Sarad Grace | Principal Accounting Officer | 2026-02-26 | Sale | 4,079.0 | $2.5 |
| Wong-Sarad Grace | Principal Accounting Officer | 2025-12-05 | Sale | 4,753.0 | $1.21 |
| Berkley Neil Lindsay | Chief Bus Ofcr & Interim CFO | 2025-12-03 | Sale | 37,261.0 | $1.12 |
| Wong-Sarad Grace | Principal Accounting Officer | 2025-12-03 | Sale | 8,056.0 | $1.12 |
| Kenkare-Mitra Sara | President and Head of R&D | 2025-12-03 | Sale | 41,687.0 | $1.12 |
| Rosenthal Arnon | Chief Executive Officer | 2025-12-03 | Sale | 104,347.0 | $1.12 |
| Wong-Sarad Grace | Principal Accounting Officer | 2025-09-02 | Sale | 5,910.0 | $2.5 |
| Berkley Neil Lindsay | Principal Financial Officer | 2025-09-02 | Sale | 15,842.0 | $2.5 |
| Kenkare-Mitra Sara | President and Head of R&D | 2025-09-02 | Sale | 23,638.0 | $2.5 |
| Rosenthal Arnon | Chief Executive Officer | 2025-09-02 | Sale | 51,562.0 | $2.5 |
| Hammond Paula | Director | 2025-08-26 | Sale | 14,000.0 | $2.36 |
| Yaffe Kristine | Director | 2025-06-20 | Sale | 1,000.0 | $1.44 |
| GRASSO MARC | Chief Financial Officer | 2025-06-02 | Sale | 16,488.0 | $1.34 |
| Kenkare-Mitra Sara | President and Head of R&D | 2025-06-02 | Sale | 23,890.0 | $1.34 |
| Rosenthal Arnon | Chief Executive Officer | 2025-06-02 | Sale | 52,087.0 | $1.34 |
| GRASSO MARC | Chief Financial Officer | 2025-03-03 | Sale | 18,091.0 | $1.47 |
| Kenkare-Mitra Sara | President and Head of R&D | 2025-03-03 | Sale | 29,073.0 | $1.47 |
| Rosenthal Arnon | Chief Executive Officer | 2025-03-03 | Sale | 40,330.0 | $1.47 |
| Romano Gary | Chief Medical Officer | 2025-03-03 | Sale | 16,306.0 | $1.47 |
| GRASSO MARC | Chief Financial Officer | 2024-12-02 | Sale | 16,489.0 | $2.52 |
| Rosenthal Arnon | Chief Executive Officer | 2024-12-02 | Sale | 52,172.0 | $2.52 |
| Kenkare-Mitra Sara | President and Head of R&D | 2024-12-02 | Sale | 26,500.0 | $2.52 |
| Romano Gary | Chief Medical Officer | 2024-12-02 | Sale | 14,892.0 | $2.52 |
| GRASSO MARC | Chief Financial Officer | 2024-09-03 | Sale | 7,297.0 | $4.88 |
| Rosenthal Arnon | Chief Executive Officer | 2024-09-03 | Sale | 26,499.0 | $4.88 |
| Kenkare-Mitra Sara | President and Head of R&D | 2024-09-03 | Sale | 13,926.0 | $4.88 |
| Romano Gary | Chief Medical Officer | 2024-09-03 | Sale | 8,478.0 | $4.88 |
| SCHELLER RICHARD H | Director | 2024-08-22 | Sale | 44,250.0 | $5.16 |
| Hammond Paula | Director | 2024-08-12 | Sale | 10,500.0 | $5.06 |
| Yaffe Kristine | Director | 2024-08-12 | Sale | 5,000.0 | $5.06 |
| Rosenthal Arnon | Chief Executive Officer | 2024-06-03 | Sale | 25,135.0 | $4.8 |
| Romano Gary | Chief Medical Officer | 2024-06-03 | Sale | 8,040.0 | $4.8 |
| Kenkare-Mitra Sara | President and Head of R&D | 2024-06-03 | Sale | 13,206.0 | $4.8 |
| GRASSO MARC | Chief Financial Officer | 2024-06-03 | Sale | 6,920.0 | $4.8 |
| Romano Gary | Chief Medical Officer | 2024-03-04 | Sale | 6,001.0 | $6.92 |
| Kenkare-Mitra Sara | President and Head of R&D | 2024-03-04 | Sale | 10,169.0 | $6.92 |
| GRASSO MARC | Chief Financial Officer | 2024-03-04 | Sale | 5,716.0 | $6.92 |
| Rosenthal Arnon | Chief Executive Officer | 2024-03-04 | Sale | 18,837.0 | $6.92 |
| Rosenthal Arnon | Chief Executive Officer | 2023-12-04 | Sale | 23,831.0 | $5.56 |
| Romano Gary | Chief Medical Officer | 2023-12-04 | Sale | 5,035.0 | $5.56 |
| GRASSO MARC | Chief Financial Officer | 2023-12-04 | Sale | 4,574.0 | $5.56 |
| Kenkare-Mitra Sara | President and Head of R&D | 2023-12-04 | Sale | 12,519.0 | $5.56 |
| Polaris Venture Partners VI, L.P. | TenPercentOwner | 2023-09-11 | Sale | 500,000.0 | $6.0 |
| Polaris Venture Partners Founders' Fund VI, L.P. | TenPercentOwner | 2023-09-11 | Sale | 500,000.0 | $6.0 |
| Polaris Venture Management Co. VI, L.L.C. | TenPercentOwner | 2023-09-11 | Sale | 500,000.0 | $6.0 |
| Polaris Venture Partners VI (AIV), L.P. | TenPercentOwner | 2023-09-11 | Sale | 500,000.0 | $6.0 |
| Polaris Venture Partners VI (AIV-B), L.P. | TenPercentOwner | 2023-09-11 | Sale | 500,000.0 | $6.0 |
| MCGUIRE TERRANCE | Director,TenPercentOwner | 2023-09-11 | Sale | 500,000.0 | $6.0 |
| Rosenthal Arnon | Chief Executive Officer | 2023-09-05 | Sale | 5,647.0 | $5.19 |
| Kenkare-Mitra Sara | President and Head of R&D | 2023-09-05 | Sale | 6,214.0 | $5.19 |
| Romano Gary | Chief Medical Officer | 2023-09-05 | Sale | 2,771.0 | $5.19 |
| GRASSO MARC | Chief Financial Officer | 2023-09-05 | Sale | 1,114.0 | $5.19 |
| Kenkare-Mitra Sara | President and Head of R&D | 2023-06-02 | Sale | 4,092.0 | $6.9 |
| GRASSO MARC | Chief Financial Officer | 2023-06-02 | Sale | 1,050.0 | $6.9 |
| Romano Gary | Chief Medical Officer | 2023-06-02 | Sale | 2,617.0 | $6.9 |
| Rosenthal Arnon | Chief Executive Officer | 2023-06-02 | Sale | 5,255.0 | $6.9 |
| Rosenthal Arnon | Chief Executive Officer | 2023-03-17 | Sale | 15,186.0 | $6.22 |
| Romano Gary | Chief Medical Officer | 2023-03-02 | Sale | 3,238.0 | $8.32 |
| Kenkare-Mitra Sara | President and Head of R&D | 2023-03-02 | Sale | 10,124.0 | $8.32 |
| GRASSO MARC | Chief Financial Officer | 2023-03-02 | Sale | 1,291.0 | $8.32 |
| Rosenthal Arnon | Chief Executive Officer | 2023-03-02 | Sale | 5,849.0 | $8.32 |
| Romano Gary | Chief Medical Officer | 2022-12-02 | Sale | 2,145.0 | $8.71 |
| Romano Gary | Chief Medical Officer | 2022-09-02 | Sale | 2,177.0 | $10.62 |
| King Robert | Chief Development Officer | 2022-09-02 | Sale | 176.0 | $10.62 |
| King Robert | Chief Development Officer | 2022-06-02 | Sale | 177.0 | $8.71 |
| King Robert | Chief Development Officer | 2022-03-01 | Sale | 287.0 | $15.57 |
| SULIMAN SHEHNAAZ | President and COO | 2021-12-13 | Sale | 10,898.0 | $21.73 |
| SULIMAN SHEHNAAZ | President and COO | 2021-12-13 | Sale | 64,102.0 | $21.16 |
| SULIMAN SHEHNAAZ | President and COO | 2021-12-10 | Sale | 8,874.0 | $22.33 |
| SULIMAN SHEHNAAZ | President and COO | 2021-12-10 | Sale | 66,126.0 | $21.69 |
| SULIMAN SHEHNAAZ | President and COO | 2021-12-09 | Sale | 2,643.0 | $23.4 |
| SULIMAN SHEHNAAZ | President and COO | 2021-12-09 | Sale | 72,357.0 | $22.8 |
| SULIMAN SHEHNAAZ | President and COO | 2021-12-08 | Sale | 38,489.0 | $23.01 |
| SULIMAN SHEHNAAZ | President and COO | 2021-12-08 | Sale | 36,511.0 | $22.56 |
| King Robert | Chief Development Officer | 2021-12-01 | Sale | 250.0 | $20.09 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-11 | Sale | 55,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-10 | Sale | 55,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-09 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-09 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-09 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-09 | Sale | 55,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-08 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-08 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-08 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-08 | Sale | 55,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-05 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-05 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-05 | Sale | 15,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-05 | Sale | 55,000.0 | $25.0 |
| Rosenthal Arnon | Chief Executive Officer | 2021-11-04 | Sale | 15,000.0 | $25.0 |